My watch list  


Companies Osteoarthritis

GeneQuine Biotherapeutics GmbH, Germany

GeneQuine develops gene therapy-based drugs for the treatment of osteoarthritis. The goal is the development of a gene therapy drug for osteoarthritis in humans. However, GeneQuine focuses initially on gaining market authorization for its drug candidates for horses and dogs, because obtaining regula more

News Osteoarthritis

  • Milestone in Osteoarthritis Research

    Researchers found new genetic risk factors for osteoarthritis and identified novel drug targets. Their finding is a milestone towards the development of the first ever curative treatment for osteoarthritis. The study involved an international consortium led by Helmholtz Zentrum München. Osteoarthrit more

  • Advance Gene Therapy Pipeline for Musculoskeletal Diseases

    GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A investmen more

  • CO.DON negotiates with Xintela on the establishment of a joint venture

    CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of stem cell based options for the treatment of cartilage disorders, spe more

All news on osteoarthritis

Publications Osteoarthritis

All publications on osteoarthritis


Osteoarthritis Osteoarthritis (OA, also known as degenerative arthritis, degenerative joint disease), is a condition in which low-grade inflammation results in pain in the joints, caused by abnormal wearing of the cartilage that covers and act ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE